Author

Chong Sun

German Cancer Research CenterORCID 0000-0001-9008-2158Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Beiping MiaoiD· 2 shared Helena EngeliD· 2 shared Shangce DuiD· 2 shared Alexander KowariD· 1 shared Ali Hyder Baig· 1 shared Cansu Eris· 1 shared Catarina PechinchaiD· 1 shared Cecilia Berzain Battioni· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Beiping MiaoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyImmunityPeer-reviewedJul 1, 2026

P2RY2 is a purinergic immune checkpoint linking extracellular ATP to immune evasion and adaptive resistance to immunotherapy

Zhaoqing Hu, Hitoshi Matsuo, Shangce Du…·Chong Sun

This paper identifies P2RY2 as a purinergic immune checkpoint that mediates eATP-driven immune evasion and adaptive resistance to immunotherapy by promoting PGE2 accumulation in the tumor microenvironment.

2 citationstop 2%

humanexperimental assay

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedMay 19, 2025

Dual Ribosome Profiling reveals metabolic limitations of cancer and stromal cells in thetumor microenvironment

Daniela Avilés Huerta, Rossella Del Pizzo, Alexander Kowar…·Fabricio Loayza‐Puch

This study uses Dual Ribosome Profiling to reveal cell type-specific metabolic limitations in the tumor microenvironment, showing how amino acid availability affects immunotherapy outcomes.

3 citations

mouseproteomics

𝕏 PostBluesky